Main results
Physicians were more likely (
p<0.001) than patients to attribute CAM use to hope (
2=17.7), control (
2=17.5), incurable disease (
2=42.8), or a nontoxic approach (
2=50.9). Both physicians and patients agreed CAM could relieve symptoms/side effects, but physicians were less likely (
p<0.001) than patients to expect that CAM improved immunity (
2=72.2) or quality of life (
2=17.1), cured disease (
2=42.5), or prolonged life (
2=58.4). Physicians and patients responded differently (
p<0.005) on reasons for nondisclosure. Physicians believed patients felt CAM discussions were unimportant (
2=7.9) and physicians would not understand (
2=48.1), discontinue treatment (
2=26.4), discourage or disapprove of the use (
2=131.7); patients attributed nondisclosure to their uncertainty of its benefit (
2=10.4) and never being asked about CAM (
2=9.9) by physicians. Physicians were more likely (
2=9.5,
p<0.002) to warn of risks and less likely (
2=23.5,
p<0.001) to encourage use than patients perceived.